GE HealthCare insider trading
Health Care · Strong buyingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 8 GE HealthCare insiders reported open-market purchases totaling $6.4M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Apr 30, 2026, when 7 insiders bought a combined $5.8M.
Insider transactions
Open-market purchases and sales. 69 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 26SEC | Kevin LoboDirector | Buy | 10,000 | $64.18 | $642K | +2.4% | — |
| May 13SEC | Rodney F HochmanDirector | Buy | 1,618 | $62.03 | $100K | +6.0% | — |
| May 11SEC | Watkin Phoebe L. YangDirector | Buy | 1,000 | $63.01 | $63K | +4.3% | — |
| May 7SEC | H Lawrence Culp Jr.Director | Buy | 80,805 | $61.88 | $5.0M | +6.2% | — |
| May 7SEC | William J StrombergDirector | Buy | 1,000 | $61.69 | $62K | +6.6% | — |
| May 1SEC | James SaccaroCFO | Buy | 3,310 | $60.60 | $201K | +8.5% | — |
| Apr 30SEC | Peter J ArduiniCEO, President | Buy | 4,169 | $59.92 | $250K | +9.7% | — |
| Apr 30SEC | Frank R JimenezGc & Corporate Secretary | Buy | 1,750 | $60.45 | $106K | +8.8% | — |
Insiders at GE HealthCare
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| H Lawrence Culp Jr.Director | $5.0M | — | May 11, 2026 | — |
| Kevin LoboDirector | $642K | — | May 26, 2026 | — |
| Peter J ArduiniCEO, President | $250K | — | Sep 4, 2026 | — |
| James SaccaroCFO | $201K | — | May 1, 2026 | — |
| Frank R JimenezGc & Corporate Secretary | $106K | — | Sep 4, 2026 | — |
| Rodney F HochmanDirector | $100K | — | May 13, 2026 | — |
| Watkin Phoebe L. YangDirector | $63K | — | May 11, 2026 | — |
| William J StrombergDirector | $62K | — | May 11, 2026 | — |
| William K GroganCFO | — | — | Sep 16, 2026 | — |
| Taha Kass-houtCTO | — | — | Sep 4, 2026 | — |
| Philip RackliffeCEO | — | — | Sep 4, 2026 | — |
| Kevin Michael O'neillCEO | — | — | Sep 4, 2026 | — |
| Adam Y HoltonChief People Officer | — | — | Sep 4, 2026 | — |
| Catherine EstrampesChief Commer. & Growth Officer | — | — | Sep 4, 2026 | — |
| George A. NewcombChief Accounting Officer | — | — | Sep 4, 2026 | — |
| Jeannette BankesCEO | — | — | Sep 3, 2026 | — |
| Catherine A LesjakDirector | — | — | May 11, 2026 | — |
| Anne T MaddenDirector | — | — | May 11, 2026 | — |
| Roland RottCEO | — | — | Mar 4, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about GEHC insiders
Are GE HealthCare insiders buying GEHC stock?
In the past 12 months, 8 insiders reported open-market purchases of GEHC worth $6.4M. The latest was Director Kevin Lobo bought $642K of GEHC at $64.18 — first open-market purchase in our records; raises the stake by 229%.
Are GE HealthCare insiders selling GEHC stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.